688073 毕得医药
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产93,291-10.42%104,146100,68942,78139,065
在建工程0--015,41405,096
无形资产4,586-7.00%4,9313,945601212
商誉7,5570.00%7,557000
其他非流动资产84,826-11.03%95,33989,263110,48070,231
190,260-10.24%211,973209,312153,862114,604

流动资产
货币资金842,403-10.52%941,4781,105,3331,274,0761,505,956
应收账款271,0766.96%253,438222,954235,010177,028
存货934,657-2.84%962,007760,217699,430521,860
其他流动资产251,15069.81%147,902120,21952,65039,757
2,299,286-0.24%2,304,8252,208,7232,261,1662,244,602

流动负债
短期借款5,0381,377.42%34130,1822319,609
应付票据500--021900
应付帐款157,498-22.21%202,460216,102179,566167,371
其他流动负债145,1154.39%139,01999,25895,17272,091
308,151-9.85%341,819345,761274,970249,071
流动资产净值1,991,1351.43%1,963,0051,862,9621,986,1961,995,531
资产总额减流动负债2,181,3940.29%2,174,9782,072,2742,140,0582,110,135

非流动负债
长期借款81,000-2.70%83,250000
应付债券0--0000
其他非流动负债38,565-16.77%46,33345,15150,51633,981
119,565-7.73%129,58345,15150,51633,981

总权益
    实收股本90,8830.00%90,88390,88390,88364,916
    储备项目1,970,9470.84%1,954,5121,936,2401,998,6592,011,238
股东权益2,061,8300.80%2,045,3952,027,1222,089,5422,076,154
非控股权益0--0000